Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Diffuse Cutaneous Systemic Sclerosis Clinical Trials

3 recruiting trials for Diffuse Cutaneous Systemic Sclerosis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
1
Phase 3 Trials
3
Sponsors

Recruiting Trials

RECRUITINGPhase 2NCT05149768

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

The purpose of this study is to assess safety and efficacy of Brentuximab vedotin, a CD30-directed antibody-drug conjugate, in patients with active diffuse cutaneous systemic...

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sEnrolling: 111 location
RECRUITINGPhase 3NCT06936215

Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With...

Systemic sclerosis (SSc) is a systemic autoimmune disease. It causes progressive skin tightening, pulmonary fibrosis, organ damage and many other physical dysfunctions. It is...

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshEnrolling: 241 location
RECRUITINGPhase 1NCT06925542

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

This is a single-arm, open-label, multicenter, ascending dose Phase 1 study evaluating the safety and preliminary efficacy of CTX112 in adult subjects with refractory autoimmune...

Sponsor: CRISPR TherapeuticsEnrolling: 808 locations